Patents by Inventor Smriti U. Mehta

Smriti U. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to hepatitis C virus and method for using same
    Patent number: 5753430
    Abstract: Monoclonal antibodies which specifically bind to either Hepatitis C Virus C-100 protein, Hepatitis C Virus 33C protein and Hepatitis C Virus CORE protein, and hybridomas which produce these monoclonal antibodies. Also provided are methods for using these monoclonal antibodies and assay kits containing these antibodies.
    Type: Grant
    Filed: September 29, 1994
    Date of Patent: May 19, 1998
    Assignee: Abbott Laboratories
    Inventors: Smriti U. Mehta, Jill Johnson, Sheela M. George, Suresh M. Desai, Larry T. Mimms, Sushil G. Devare, Joan D. Tyner, Mary S. Gibadlo
  • Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
    Patent number: 5308750
    Abstract: Monoclonal antibodies which specifically bind to Hepatitis C Virus (HCV) E2/NS1 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits for assays which contain these monoclonal antibodies.
    Type: Grant
    Filed: August 21, 1991
    Date of Patent: May 3, 1994
    Assignee: Abbott Laboratories
    Inventors: Smriti U. Mehta, Jill E. Johnson, Stephen H. Dailey, Suresh M. Desai, Sushil G. Devare
  • Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
    Patent number: 5173399
    Abstract: The present invention provides monoclonal antibodies demonstrating specific reactivity with HIV-1 p24. One monoclonal antibody designated 31-42-19 recognizes an unique epitope on HIV-1 p24 that is not immunogenic in humans. 31-42-19 also reacts with an antigenically cross reactive epitope on HIV-2 p24. Another monoclonal antibody designated 31-90-25 recognizes an epitope within a highly immunogenic region of HIV-1 p24. The present invention also provides cell lines capable of producing these monoclonal antibodies. The invention also includes a highly sensitive enzyme immunoassay for the detection of HIV-1 p24 in biological fluids, using a monoclonal antibody mixture. The present invention further provides methods for the use of these monoclonal antibodies for the detection of anti-HIV-1 p24 antibodies and HIV-2 p24 antigen in biological samples.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: December 22, 1992
    Assignee: Abbott Laboratories
    Inventors: Smriti U. Mehta, Jeffrey C. Hunt, Sushil G. Devare